Clinical Trial Update: Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL [Phase 2]

View source ↗

Summary

Phase 2 trial of pentostatin, cyclophosphamide, and rituximab followed by Campath-1H in relapsed/refractory B-cell chronic lymphocytic leukemia has completed wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Campath-1H (alemtuzumab)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2019-02-27